CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
CERE
Delisted
CERE was delisted on the 31st of July, 2024.
82 hedge funds and large institutions have $2.64B invested in Cerevel Therapeutics Holdings, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
Holders
82
Holding in Top 10
2
Calls
$11.6M
Puts
$2.99M
Top Buyers
| 1 | +$95.4M | |
| 2 | +$39.8M | |
| 3 | +$23M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$9.67M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$7.95M |
Top Sellers
| 1 | -$27M | |
| 2 | -$23.1M | |
| 3 | -$12.8M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$12.2M |
| 5 |
Bank of New York Mellon
New York
|
-$11.5M |